Do Traders Think MannKind Corp (MNKD) Can Keep Climbing Monday?

MannKind Corp (MNKD) stock is higher by 0.69% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

MannKind Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on MNKD!

See Full MNKD Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With MNKD Stock Today?

MannKind Corp (MNKD) stock is trading at $4.38 as of 10:23 AM on Monday, Sep 18, an increase of $0.03, or 0.57% from the previous closing price of $4.35. The stock has traded between $4.37 and $4.64 so far today. Volume today is light. So far 882,426 shares have traded compared to average volume of 3,546,397 shares. To see InvestorsObserver's Sentiment Score for MannKind Corp click here.

More About MannKind Corp

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler. Click Here to get the full Stock Report for MannKind Corp stock.